Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management
- 29 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (Supplement), iii84-iii94
- https://doi.org/10.1093/rheumatology/kez570
Abstract
Eosinophilic granulomatosis with polyangiitis is characterized by asthma, blood and tissue eosinophilia and small-vessel vasculitis. The clinical presentation is variable, but two main clinic-pathologic subsets can be distinguished: one hallmarked by positive ANCA and predominant ‘vasculitic’ manifestations (e.g. glomerulonephritis, purpura and mononeuritis multiplex) and the other by negative ANCA and prominent ‘eosinophilic’ manifestations (e.g. lung infiltrates and cardiomyopathy). The pathogenesis is not fully understood but probably results from the interplay between T and B cells and eosinophils. Eosinophilic granulomatosis with polyangiitis must be differentiated from several conditions, including hypereosinophilic syndromes and other small-vessel vasculitides. The overall survival is good; however, patients frequently relapse and have persistent symptoms. The recently developed monoclonal antibodies targeting B cells and eosinophilopoietic cytokines such as IL-5 are emerging as valid alternatives to conventional immunosuppressive therapies. In this review, we discuss the essential features of eosinophilic granulomatosis with polyangiitis, with particular respect to the most relevant issues concerning clinical presentation and management.Keywords
Funding Information
- University of Cambridge
This publication has 94 references indexed in Scilit:
- Severe adult-onset asthma: A distinct phenotypeJournal of Allergy and Clinical Immunology, 2013
- Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg–Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiographyThe International Journal of Cardiovascular Imaging, 2012
- A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patientsAnnals Of The Rheumatic Diseases, 2012
- Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UKRheumatology, 2011
- Rituximab for the treatment of Churg-Strauss syndrome with renal involvementNephrology Dialysis Transplantation, 2011
- Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic studyRheumatology, 2011
- Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1Haematologica, 2010
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- Peripheral neuropathy in Wegener's granulomatosis, Churg Strauss syndrome and microscopic polyangiitisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studiesAnnals Of The Rheumatic Diseases, 2006